FDA risk management public hearing
Executive Summary
FDA's Center for Drug Evaluation & Research will hold a public hearing on risk management for prescription drugs May 22 at 8 a.m. at the National Transportation Safety Board conference center in Washington, D.C. Meeting follows up on the work of FDA/PhRMA risk management "toolkit" initiative (11"The Pink Sheet" Dec. 17, 2001, p. 28)...